Page 1328 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1328
References 3
61. Klimo P Jr., Thompson CJ, Kestle JR, Schmidt MH. A 78. Vecht CJ, Haaxma-Reiche H, van Putten WL, de Visser M,
meta-analysis of surgery versus conventional radiotherapy for Vries EP, Twijnstra A. Initial bolus of conventional versus high-
the treatment of metastatic spinal epidural disease. Neuro Oncol. dose dexamethasone in metastatic spinal cord compression.
January 2005;7(1):64-76. Neurology. September 1989;39(9):1255-1257.
62. Eleraky M, Papanastassiou I, Vrionis FD. Management of meta- 79. Sciubba DM, Gokaslan ZL. Diagnosis and management of
static spine disease. Curr Opin Support Palliat Care. September metastatic spine disease. Surg Oncol. November 2006;15(3):
2010;4(3):182-188. 141-151.
63. Kienstra GE, Terwee CB, Dekker FW, et al. Prediction of spinal 80. Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarach-
epidural metastases. Arch Neurol. May 2000;57(5):690-695. noid hemorrhage in patients with cancer. Neurology. February 9,
64. Sun H, Nemecek AN. Optimal management of malignant 2010;74(6):494-501.
epidural spinal cord compression. Hematol Oncol Clin North 81. Quinn JA, DeAngelis LM. Neurologic emergencies in the cancer
Am. June 2010;24(3):537-551. patient. Semin Oncol. June 2000;27(3):311-321.
65. McCurdy MT, Shanholtz CB. Oncologic emergencies. Crit Care 82. Rogers LR. Cerebrovascular complications in patients with
Med. July 2012;40(7):2212-2222. cancer. Semin Neurol. December 2004;24(4):453-460.
66. Hamamoto Y, Kataoka M, Senba T, et al. Vertebral metastases 83. Najima Y, Ohashi K, Miyazawa M, et al. Intracranial hemorrhage
with high risk of symptomatic malignant spinal cord compres- following allogeneic hematopoietic stem cell transplantation.
sion. Jpn J Clin Oncol. July 2009;39(7):431-434. Am J Hematol. May 2009;84(5):298-301.
67. Rodichok LD, Ruckdeschel JC, Harper GR, et al. Early detection 84. Gonzalez-Duarte A, Garcia-Ramos GS, Valdes-Ferrer SI,
and treatment of spinal epidural metastases: the role of myelog- Cantu-Brito C. Clinical description of intracranial hemorrhage
raphy. Ann Neurol. December 1986;20(6):696-702. associated with bleeding disorders. J Stroke Cerebrovasc Dis.
68. Helweg-Larsen S, Sorensen PS. Symptoms and signs in meta- July-August 2008;17(4):204-207.
static spinal cord compression: a study of progression from 85. Chang MC, Chen TY, Tang JL, et al. Leukapheresis and cranial
first symptom until diagnosis in 153 patients. Eur J Cancer. irradiation in patients with hyperleukocytic acute myeloid
1994;30A(3):396-398. leukemia: no impact on early mortality and intracranial hemor-
69. Ruckdeschel JC. Rapid, cost-effective diagnosis of spinal cord rhage. Am J Hematol. November 2007;82(11):976-980.
compression due to cancer. Cancer Control. July 1995;2(4): 86. Ruggiero A, Attina G, Piastra M, et al. Severe hyperleukocytosis
320-323. and multifocal intracranial haemorrhage: not always a fatal
70. Enkaoua EA, Doursounian L, Chatellier G, Mabesoone F, outcome. Int J Hematol. July 2009;90(1):87-90.
Aimard T, Saillant G. Vertebral metastases: a critical apprecia- 87. Chen CY, Tai CH, Tsay W, Chen PY, Tien HF. Prediction of
tion of the preoperative prognostic tokuhashi score in a series fatal intracranial hemorrhage in patients with acute myeloid
of 71 cases. Spine (Phila Pa 1976). October 1, 1997;22(19): leukemia. Ann Oncol. June 2009;20(6):1100-1104.
2293-2298. 88. Rogers LR. Cerebrovascular complications in cancer patients.
71. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A Neurol Clin. February 2003;21(1):167-192.
revised scoring system for preoperative evaluation of meta- 89. Wijman CA, Venkatasubramanian C, Bruins S, Fischbein
static spine tumor prognosis. Spine (Phila Pa 1976). October 1, N, Schwartz N. Utility of early MRI in the diagnosis and
2005;30(19):2186-2191. management of acute spontaneous intracerebral hemorrhage.
72. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Cerebrovasc Dis. 2010;30(5):456-463.
Akamaru T. Surgical strategy for spinal metastases. Spine (Phila 90. Nyquist P. Management of acute intracranial and intraventricu-
Pa 1976). February 1, 2001;26(3):298-306. lar hemorrhage. Crit Care Med. March 2010;38(3):946-953.
73. van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer 91. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic
JW. Prediction of survival in patients with metastases in the spi- acid in acute promyelocytic leukemia. N Engl J Med. October 9,
nal column: results based on a randomized trial of radiotherapy. 1997;337(15):1021-1028.
Cancer. January 15, 2005;103(2):320-328.
74. Harrington KD. Orthopedic surgical management of skel- 92. Body JJ. Hypercalcemia of malignancy. Semin Nephrol. January
2004;24(1):48-54.
etal complications of malignancy. Cancer. October 15, 1997;80
(8 suppl):1614-1627. 93. Stewart AF. Clinical practice. Hypercalcemia associated with
75. Loblaw DA, Mitera G, Ford M, Laperriere NJ. A 2011 Updated cancer. N Engl J Med. January 27, 2005;352(4):373-379.
systematic review and clinical practice guideline for the man- 94. Sargent JT, Smith OP. Haematological emergencies managing
agement of malignant extradural spinal cord compression. Int hypercalcaemia in adults and children with haematological
J Radiat Oncol Biol Phys. October 1, 2012;84(2):312-317. disorders. Br J Haematol. May 2010;149(4):465-477.
76. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive 95. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator
surgical resection in the treatment of spinal cord compression of hypercalcemia in Hodgkin’s disease and non-Hodgkin’s lym-
caused by metastatic cancer: a randomised trial. Lancet. August phomas. Blood. September 1, 1993;82(5):1383-1394.
20-26, 2005;366(9486):643-648. 96. Deftos LJ. Hypercalcemia in malignant and inflammatory
77. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect diseases. Endocrinol Metab Clin North Am. March 2002;
of high-dose dexamethasone in carcinomatous metastatic spinal 31(1):141-158.
cord compression treated with radiotherapy: a randomised trial. 97. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-
Eur J Cancer. 1994;30A(1):22-27. associated hypercalcemia: morbidity and mortality. Clinical
Section07-O-ref.indd 3 1/21/2015 11:26:50 AM

